If you're searching for a Xultophy savings card hoping to sign up for a manufacturer copay discount, here's the direct answer: it's not there anymore. Novo Nordisk's current list of savings offers covers products like Ozempic, Awiqli, Tresiba, Fiasp, and NovoLog — Xultophy 100/3.6 isn't among them.
That's a frustrating discovery, especially because Xultophy doesn't have the usual safety net other brand-name drugs offer: there's no generic version to fall back on. It's a combination of insulin degludec and liraglutide in one pen, and no lower-cost equivalent has reached the U.S. market.
This guide walks through exactly what happened to the Xultophy savings card, what the medication actually costs in 2026, and how to figure out whether a discount card or the Novo Nordisk Patient Assistance Program is the better fit for your situation.
What Happened to the Xultophy Savings Card
Novo Nordisk previously offered an "Instant Savings Card" for Xultophy that let commercially insured patients pay as little as $1 a day, with a maximum monthly savings of $400 for up to 24 months and a free box of needles included. That offer is no longer part of the company's active savings lineup. Checking Novo Nordisk's own current savings offers page confirms this directly: Xultophy simply isn't listed among the insulin or non-insulin savings offers currently available, while several other diabetes medicines still are.
| Question | Current Answer (2026) |
|---|---|
| Is the Novo Nordisk Xultophy copay card still active? | No — discontinued |
| Can I still sign up for it at novocare.com? | No active enrollment offer for Xultophy |
| Does Novo Nordisk still help patients afford Xultophy? | Yes — through the Xultophy Patient Assistance Program, a different type of program |
| Is there a generic alternative available now? | No — no generic or biosimilar exists |
Why the confusion? Several coupon aggregator sites still list a "Xultophy manufacturer offer" alongside their own discount cards, and some explicitly note the manufacturer offer "has ended" in fine print that's easy to miss. Third-party discount cards are a separate tool from a manufacturer copay card, and they're still very much active — they're just not the same thing as the discontinued Novo Nordisk offer.
The Discontinued Card: How It Used to Work
For context — and because plenty of people are searching for exactly this — here's how the Xultophy Instant Savings Card functioned while it was active.
| Feature | Detail (Historical) |
|---|---|
| Maximum benefit | As little as $1 per day, with eligible commercial insurance |
| Monthly cap | Up to $400 in monthly savings |
| Duration | Valid for up to 24 months of use |
| Who qualified | Commercially (privately) insured patients only |
| Who was excluded | Medicare, Medicaid, and other government insurance beneficiaries |
| Extra perk | A free box of Novo Nordisk needles was included with enrollment |
If you were relying on this card and your pharmacy now rejects it, that's expected — the offer has ended, not a pharmacy processing error.
Current Options: What Replaced the Savings Card
Because there's no generic and no active manufacturer card, your options for Xultophy narrow down to three genuinely different paths depending on your insurance status.
| Option | Best For | Typical Cost |
|---|---|---|
| Free pharmacy discount card (SingleCare, GoodRx) | Commercially insured or uninsured patients comparing prices | ~$238 per 3 mL pen |
| Insurance copay (commercial or Part D formulary) | Insured patients whose plan covers Xultophy | Varies widely by plan and tier |
| Novo Nordisk Patient Assistance Program (free) | Uninsured or Medicare-only, income-eligible patients | $0 |
| Cash price, no coupon | Not recommended — highest-cost option | ~$542 per pen |
Eligibility Comparison: Then vs. Now
| Situation | Old Savings Card | Current Best Option |
|---|---|---|
| Commercially insured | Would have applied — as little as $1/day | No manufacturer card — compare copay to a discount card |
| Uninsured | Never eligible | Discount card, or PAP if income-eligible |
| Medicare only, no other coverage | Never eligible | Patient Assistance Program if income-eligible |
| Medicare with Part D drug coverage | Never eligible | Use Part D coverage; PAP generally not needed if the plan already pays for Xultophy |
Cost Comparison: Cash Price vs. Discount Card vs. PAP
| Scenario | Price per 3 mL Pen | Notes |
|---|---|---|
| Full cash price, no coupon | ~$542 | Baseline average retail price |
| Free discount card (SingleCare/GoodRx) | ~$238 | Works regardless of insurance status; can't be combined with insurance |
| Commercial insurance copay | Varies | Depends on formulary tier and deductible status — compare to the discount card price |
| Novo Nordisk Patient Assistance Program | $0 | Income-eligible uninsured or Medicare-only patients only |
Your actual monthly cost depends on your prescribed daily dose, since higher doses require more than one pen per month. Ask your pharmacist to calculate your specific monthly total under each pricing path before you decide.
What the Novo Nordisk PAP Covers
The Novo Nordisk Patient Assistance Program isn't limited to Xultophy — it's the company's broader program covering a range of diabetes medications for eligible uninsured and Medicare-only patients.
| Category | Examples |
|---|---|
| Combination insulin / GLP-1 | Xultophy 100/3.6 (insulin degludec and liraglutide) |
| Insulins | Tresiba, NovoLog, NovoLog Mix 70/30, Fiasp, Awiqli |
| GLP-1 receptor agonists | Ozempic (subject to its own, stricter income and Part D rules) |
Novo Nordisk reviews the PAP product list each year, and some medicines have been removed from the program in past cycles. Confirm Xultophy is still on the current product list before applying, and know that Ozempic follows a separate, more restrictive set of income rules than the rest of the portfolio.
Income Limit Comparison for the PAP
For Xultophy and most other Novo Nordisk products (outside the Ozempic-specific rule), 2026 program eligibility is based on 400% of the Federal Poverty Level (FPL) for both uninsured patients and Medicare-only patients. Treat this table as a planning estimate.
| Household Size | ~100% FPL | ~400% FPL (general PAP threshold) |
|---|---|---|
| 1 person | ~$15,650 | ~$62,600 |
| 2 people | ~$21,150 | ~$84,600 |
| 3 people | ~$26,650 | ~$106,600 |
| 4 people | ~$32,150 | ~$128,600 |
Medicare patients: if household income is below 150% FPL, you're required to first apply for Extra Help (LIS) and submit your denial letter with the PAP application. Medicare patients who are approved stay enrolled through the end of the current calendar year, not a rolling 12-month term.
How to Actually Save on Xultophy Right Now: Step by Step
Compare your insurance copay against a free discount card
Pull up SingleCare or GoodRx pricing for your exact pen count before you get to the pharmacy — see our GoodRx vs Inside Rx comparison for how these tools differ — and ask the pharmacist to run whichever is cheaper.
If your plan doesn't cover Xultophy well
Ask your prescriber whether a prior authorization or formulary exception could help. See our Prior Authorization Guides for how that process typically works.
If you're uninsured or have Medicare only
Check the current income limits and apply to the Xultophy Patient Assistance Program if you qualify.
Ask your prescriber about your regimen as a whole
Because Xultophy combines a long-acting insulin with a GLP-1 medicine, some patients and prescribers find it useful to discuss whether the individual components make sense for their coverage — this is a clinical decision to make with your provider, not a switch to make on your own.
Compare pharmacy prices before you fill
Use our Drug Price Checker to see how cash and discount-card prices for Xultophy vary at pharmacies near you.
Applying to the Xultophy Patient Assistance Program
Confirm your insurance status qualifies
You must be uninsured or have Medicare only — commercially insured patients are not eligible for this program, regardless of income.
Check your household income against the current threshold
Generally at or below 400% of the Federal Poverty Level, based on total household income.
Start the online application
Complete the patient portion of the application through the Novo Nordisk PAP portal, providing an accurate email address so your prescriber's office can complete their section.
Gather your required documents
Medicare patients need a copy of their LIS denial letter if income is under 150% FPL; uninsured patients in states with income-based Medicaid thresholds need a Medicaid denial letter; residents of Maine or Minnesota need a photo government ID; and anyone who didn't file taxes needs recent pay stubs or other proof of income.
Wait for review and approval notice
You'll receive a letter by mail, plus an automated call or text if you opted in, once a decision is made.
Coordinate delivery with the specialty pharmacy
If approved, expect a call from the program's specialty pharmacy partner to schedule shipment of your medicine directly to your home at no cost to you.
Approval Timelines and Renewal
| Stage | Typical Timeframe |
|---|---|
| Complete application with all documents | 2 business days |
| Application missing documents | Delayed until resubmission is complete |
| Medicine shipped after approval | Within 5 business days |
| Uninsured patient enrollment period | 12 months, then reapplication required |
| Medicare patient enrollment period | Through the end of the current calendar year |
| Discount card savings (SingleCare/GoodRx) | Instant — no application needed |
You can submit a renewal application up to 30 days before your current enrollment ends. Medicare Part D patients can apply for the following year's enrollment starting after October 15.
Decision Tree: Which Option Fits You?
Do you have commercial insurance?
This determines which path applies to you
Does your plan cover Xultophy well?
Check your formulary tier and copay amount
Compare copay to a discount card
Use whichever price is lower at the pharmacy
Is household income under ~400% FPL?
Check the current threshold for your household size
Apply to the Patient Assistance Program
If not eligible, use a discount card instead
Still unaffordable?
Ask your prescriber whether the individual components fit your coverage better
Pros and Cons of Each Option
Discount Card — Pros
- No application, no waiting — works immediately at the pharmacy
- Available regardless of insurance status
- Cuts the cash price by more than half in most cases
- No income documentation required
Patient Assistance Program — Cons
- Requires an application and income documentation
- Not available to commercially insured patients at all
- Medicare enrollment resets at year-end, not on a rolling 12-month basis
- Program product list is reviewed annually and can change
Common Mistakes to Avoid
- □ Searching for a Xultophy manufacturer savings card sign-up page — it no longer exists.
- □ Assuming a generic version of Xultophy exists — it doesn't, as of 2026.
- □ Trying to combine a discount card with insurance at the pharmacy — you have to choose one.
- □ Applying to the Patient Assistance Program while commercially insured — it will be declined.
- □ Letting a PAP enrollment lapse without reapplying before the deadline.
- □ Assuming Ozempic's income rules apply to Xultophy — Ozempic has its own, stricter thresholds.
The most common mistake is spending time hunting for a discontinued card instead of comparing a discount card price to your actual insurance copay — that single comparison is where most of the savings are found now.
Real Examples
Example 1 — Looking for the old card: A patient searches "Xultophy savings card sign up" expecting the old $1-a-day offer, finds it's discontinued, and instead compares prices. A SingleCare coupon brings their price from a $542 cash price down to about $238 per pen.
Example 2 — Commercially insured, high copay: A patient's insurance places Xultophy on a high non-preferred tier. Their prescriber submits a formulary exception request, and the plan later approves coverage at a lower tier, cutting the copay significantly.
Example 3 — Uninsured, income-eligible: A patient with no insurance and income under the 2026 PAP threshold applies through the online portal. After a quick review, Xultophy is approved at no cost and shipped directly to their home.
Bottom Line
The Xultophy manufacturer savings card is discontinued — if you're searching for a sign-up page, it no longer exists. Unlike some other brand-name drugs, there's no generic to fall back on either, which makes the remaining options more important to understand. A free discount card typically brings the price from around $542 down to roughly $238 per pen, and the Novo Nordisk Patient Assistance Program can provide it at no cost to eligible uninsured or Medicare-only patients.
Start by comparing your insurance copay against a discount card price. If you're uninsured or on Medicare only and your income qualifies, the Patient Assistance Program is worth applying to next.